Curatis Holding Ltd header image

Curatis Holding Ltd

CURN

Equity

ISIN CH1330780979 / Valor 133078097

SIX Swiss Exchange (2026-08-28)
CHF 20.50+6.22%

Curatis Holding Ltd
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

Curatis Holding Ltd is a Swiss-based pharmaceutical company specializing in the acquisition, licensing, distribution, and promotion of medicines for the treatment and prevention of orphan and specialty diseases. The company holds exclusive distribution rights for over 30 different drugs within Switzerland, many of which target rare and specialized medical conditions. Curatis is actively working to expand its market presence by securing distribution rights in major European markets, including Germany, France, the UK, and Italy. In the medium to long term, the company plans to launch its own products pending regulatory approval. Curatis' growth strategy is bolstered by its aim to increase visibility and funding opportunities through potential public listing. The executive management team, including CFO Patrick Ramsauer, brings extensive experience in finance and corporate governance, further supporting the company's strategic objectives.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

78.3%1Y
%3Y
%5Y

Performance

71.0%1Y
95.3%3Y
95.3%5Y

Volatility

Market cap

79 M

Market cap (USD)

Daily traded volume (Shares)

151

Daily traded volume (Shares)

1 day high/low

13.5 / 13

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Globus Medical Inc
Globus Medical Inc Globus Medical Inc Valor: 18329123
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.52%USD 82.97
Tenet Healthcare Corp
Tenet Healthcare Corp Tenet Healthcare Corp Valor: 19722583
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.35%USD 266.80
Laurus Labs Ltd.
Laurus Labs Ltd. Laurus Labs Ltd. Valor: 56464789
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.80%INR 1,935.30
Tempus AI Inc
Tempus AI Inc Tempus AI Inc Valor: 135855934
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-9.41%USD 64.04
NATCO Pharma Limited
NATCO Pharma Limited NATCO Pharma Limited Valor: 30461955
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.57%INR 853.35
Teladoc Health Inc
Teladoc Health Inc Teladoc Health Inc Valor: 28438140
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.20%USD 6.50
Healthcare Services Group Inc
Healthcare Services Group Inc Healthcare Services Group Inc Valor: 938239
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.18%USD 22.44
Amgen Inc
Amgen Inc Amgen Inc Valor: 907582
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.05%USD 432.42
Ardent Health Partners Inc
Ardent Health Partners Inc Ardent Health Partners Inc Valor: 136301364
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.27%USD 10.96
BioVersys AG
BioVersys AG BioVersys AG Valor: 21036264
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
8.50%CHF 26.80